Financhill
Back

Merus NV 10K Form

Buy
64

MRUS
Merus NV

Last Price:
45.02
Seasonality Move:
-11.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRUS News And Ratings

See the #1 stock for the next 7 days that we like better than MRUS

MRUS Financial Statistics

Sales & Book Value

Annual Sales: $41.59M
Cash Flow: $-27.57M
Price / Cash Flow: 0
Annual Sales: $6.81
Price / Book: 6.6

Profitability

EPS (TTM): -3.76000
Net Income (TTM): $-176.76M
Gross Margin: $-24.6M
Return on Equity: -62.5%
Return on Assets: -44.5%

Merus NV Earnings Forecast

Key Merus NV Financial Ratios

  • The Gross Profit Margin over the past 5 years for MRUS is -98.95%.
  • The Selling, General & Administrative Expenses for MRUS have been equal to 125.52% of Gross Profit Margin.
  • The Research & Development expenses have been 359.31% of Revenue.
  • The Interest Expense is -0.19% of Operating Income.
  • The Net Earning history of MRUS is -315.48% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 2 years.

Merus NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: MRUS
CUSIP: N5749R
Website: merus.nl

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.29
Quick Ratio: 6.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRUS Technical Analysis vs Fundamental Analysis

Buy
64
Merus NV (MRUS) is a Buy

Is Merus NV a Buy or a Sell?

  • Merus NV stock is rated a Buy
    The current Merus NV [MRUS] share price is $44.99. The Score for MRUS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.